Chimin Health Management Co., Ltd. (603222.SS)
CNY 6.07
(-0.82%)
CNY 6.07
(-0.82%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 894.5 Million CNY | 6.84% |
| 2022 | 837.23 Million CNY | -23.78% |
| 2021 | 1.09 Billion CNY | 25.16% |
| 2020 | 877.64 Million CNY | 13.79% |
| 2019 | 771.27 Million CNY | 10.53% |
| 2018 | 697.83 Million CNY | 15.75% |
| 2017 | 602.89 Million CNY | 33.86% |
| 2016 | 450.37 Million CNY | 0.4% |
| 2015 | 448.59 Million CNY | -8.13% |
| 2014 | 488.3 Million CNY | -12.71% |
| 2013 | 559.42 Million CNY | -4.0% |
| 2012 | 582.75 Million CNY | 6.27% |
| 2011 | 548.36 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 230.68 Million CNY | 6.37% |
| 2024 Q2 | 232.1 Million CNY | 0.61% |
| 2024 Q3 | 213.99 Million CNY | -7.8% |
| 2023 Q1 | 222.59 Million CNY | 12.78% |
| 2023 Q2 | 221.74 Million CNY | -0.38% |
| 2023 Q3 | 233.28 Million CNY | 5.2% |
| 2023 Q4 | 216.88 Million CNY | -7.03% |
| 2023 FY | 894.5 Million CNY | 6.84% |
| 2022 Q2 | 151.68 Million CNY | -46.87% |
| 2022 Q1 | 285.49 Million CNY | -8.47% |
| 2022 FY | 837.23 Million CNY | -23.78% |
| 2022 Q4 | 197.37 Million CNY | -2.61% |
| 2022 Q3 | 202.67 Million CNY | 33.61% |
| 2021 Q3 | 252.34 Million CNY | -10.01% |
| 2021 Q4 | 311.92 Million CNY | 23.61% |
| 2021 FY | 1.09 Billion CNY | 25.16% |
| 2021 Q2 | 280.42 Million CNY | 10.5% |
| 2021 Q1 | 253.77 Million CNY | -6.88% |
| 2020 Q4 | 272.52 Million CNY | 4.07% |
| 2020 FY | 877.64 Million CNY | 13.79% |
| 2020 Q1 | 131.8 Million CNY | -31.72% |
| 2020 Q2 | 211.42 Million CNY | 60.4% |
| 2020 Q3 | 261.88 Million CNY | 23.87% |
| 2019 Q2 | 186.27 Million CNY | -3.42% |
| 2019 FY | 771.27 Million CNY | 10.53% |
| 2019 Q1 | 192.87 Million CNY | 21.73% |
| 2019 Q3 | 199.08 Million CNY | 6.88% |
| 2019 Q4 | 193.03 Million CNY | -3.04% |
| 2018 Q4 | 158.45 Million CNY | -16.68% |
| 2018 Q3 | 190.17 Million CNY | 2.84% |
| 2018 Q2 | 184.91 Million CNY | 12.55% |
| 2018 Q1 | 164.29 Million CNY | 7.84% |
| 2018 FY | 697.83 Million CNY | 15.75% |
| 2017 FY | 602.89 Million CNY | 33.86% |
| 2017 Q4 | 152.35 Million CNY | -8.33% |
| 2017 Q3 | 166.2 Million CNY | 9.99% |
| 2017 Q1 | 133.22 Million CNY | 9.73% |
| 2017 Q2 | 151.1 Million CNY | 13.42% |
| 2016 Q1 | 102.55 Million CNY | -0.62% |
| 2016 Q3 | 121 Million CNY | 14.8% |
| 2016 Q4 | 121.4 Million CNY | 0.33% |
| 2016 Q2 | 105.4 Million CNY | 2.78% |
| 2016 FY | 450.37 Million CNY | 0.4% |
| 2015 Q1 | 113.59 Million CNY | -2.38% |
| 2015 Q2 | 110.18 Million CNY | -3.0% |
| 2015 Q3 | 121.61 Million CNY | 10.37% |
| 2015 Q4 | 103.19 Million CNY | -15.14% |
| 2015 FY | 448.59 Million CNY | -8.13% |
| 2014 Q3 | 127.09 Million CNY | -1.49% |
| 2014 Q4 | 116.36 Million CNY | -8.45% |
| 2014 Q1 | 115.83 Million CNY | 0.0% |
| 2014 FY | 488.3 Million CNY | -12.71% |
| 2014 Q2 | 129.01 Million CNY | 11.38% |
| 2013 FY | 559.42 Million CNY | -4.0% |
| 2012 FY | 582.75 Million CNY | 6.27% |
| 2011 FY | 548.36 Million CNY | 0.0% |